跳至主要内容
临床试验/IRCT20220521054947N1
IRCT20220521054947N1招募中3 期

Evaluation of effect of flaxseed oil on the non invasive liver marker's in patients with nonalcoholic fatty liver disease and comparison with placebo

Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 60 years(—)
性别
All

入选标准

  • Patient satisfaction
  • AST and ALT level at least 1/5 times normal with ultrasound confirmation of fatty liver
  • Age: 15 to 60

排除标准

  • Consumption or history of alcohol consumption
  • Positive serology of viral hepatitis (C, B)
  • ANA or AMA, alpha 1 antitrypsin positive test, low serum ceruloplasin level or high level of ASMA and LKM14 antibodies
  • Ferritin above 450 or 45% IRON / TIBC> 5
  • The patient develops an acute or chronic illness before or during the intervention that interferes with LFT (liver function tests)
  • The patient take a drug before or during the intervention that has the potential to interfere with LFT
  • Age less than 15 years and more than 60 years
  • Taking herbal medicine

研究者

相似试验